A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.

Tsegay, Kaleb B; Adeyemi, Christiana M; Gniffke, Edward P; Sather, D Noah; Walker, John K; Smith, Stephen E P.

Afiliação

Tsegay KB; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
Adeyemi CM; St. Louis University School of Medicine, Department of Pharmacology and Physiology, St. Louis, MO, United States.
Gniffke EP; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
Sather DN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Walker JK; Department of Pediatrics, University of Washington, Seattle, WA, United States.
Smith SEP; St. Louis University School of Medicine, Department of Pharmacology and Physiology, St. Louis, MO, United States.

Front Pharmacol ; 12: 685308, 2021.

Article em En | MEDLINE | ID: mdl-34194331